SANGAMO THERAPEUTICS, INC (SGMO) › Shares OutstandingSANGAMO THERAPEUTICS, INC (SGMO) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 45.38M2011: 52.55M2012: 53.06M2013: 62.24M2014: 69.06M2015: 70.35M2016: 70.87M2017: 85.60M2018: 102.19M2019: 115.97M2020: 142.06M2021: 145.92M2022: 166.79M2023: 178.13M2024: 212.84M2025: 350.69M350.69M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025350.69M+64.8%2024212.84M+19.5%2023178.13M+6.8%2022166.79M+14.3%2021145.92M+2.7%2020142.06M+22.5%2019115.97M+13.5%2018102.19M+19.4%201785.60M+20.8%201670.87M+0.7%201570.35M+1.9%201469.06M+11.0%201362.24M+17.3%201253.06M+1.0%201152.55M+15.8%201045.38M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share